Home › Cancro orofaringeo › New Jersey
Studi clinici su Cancro orofaringeo nello stato di New Jersey
8 studi su Cancro orofaringeo cercano partecipanti presso sedi nello stato di New Jersey.
Città nello stato di New Jersey
Testo ufficiale dello studio (inglese)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Cooper Hospital University Medical Center, Camden
- Jersey City Medical Center, Jersey City
- Cooperman Barnabas Medical Center, Livingston
- e altri 4
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT07195734Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
- Rutgers New Jersey Medical School, Newark
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05172245E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT05639972E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Rutgers Cancer Institute, New Brunswick
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT05686226A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 mag 2026 · NCT06984861A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT05491512A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
- Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 apr 2026 · NCT05307939A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 feb 2026 · NCT07063212Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.